Effect of midodrine on HVPG in advanced chronic liver disease and acute-on-chronic liver failure-A pilot study.

Chitranshu VashishthaAnkit BhardwajAnkur Jindal Manoj Kumar Sharma Shiv Kumar Sarin

Published in: Liver international : official journal of the International Association for the Study of the Liver (2024)

In decompensated cirrhosis and ACLF patients with contraindications to NSBB, midodrine is useful in decreasing HVPG. Dose of midodrine should be titrated to increase MAP atleast by 8.5 mmHg.

Keyphrases

liver failure
hepatitis b virus
heart failure
drug induced
ejection fraction